UDCA has demonstrated some therapeutic effect in early-stage PFIC2, but its efficacy is limited in advanced disease where there is severe depletion of BSEP on the canalicular membrane.4 -PB is another medication that has been used to treat severe forms of BSEP deficiency. The gene discussed is ABCB11; the disease is hyperinsulinemic hypoglycemia, familial, 4.